Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.34% | 5.01% | 4.19% | 2.70% | 0.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.34% | 5.01% | 4.19% | 2.70% | 0.76% |
| Cost of Revenue | 7.28% | 6.84% | 5.33% | 2.37% | -1.46% |
| Gross Profit | 2.92% | 2.71% | 2.76% | 3.13% | 3.70% |
| SG&A Expenses | 1.72% | 1.29% | 1.72% | 1.64% | 2.11% |
| Depreciation & Amortization | 3.40% | 1.41% | -6.69% | -13.28% | -17.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.13% | 4.67% | 3.85% | 1.94% | -0.30% |
| Operating Income | 7.49% | 8.55% | 7.82% | 10.93% | 13.04% |
| Income Before Tax | 367.30% | 117.59% | 160.12% | 195.27% | -78.75% |
| Income Tax Expenses | 21.38% | -4.95% | 3.53% | 9.61% | 32.40% |
| Earnings from Continuing Operations | 501.81% | 448.96% | 5,101.32% | 6,566.88% | -119.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 576.90% | 326.32% | -77.98% | -81.11% | -48.95% |
| Net Income | 536.28% | 543.53% | 3,031.95% | 3,847.77% | -118.36% |
| EBIT | 7.49% | 8.55% | 7.82% | 10.93% | 13.04% |
| EBITDA | 7.75% | 8.62% | 7.92% | 10.63% | 12.41% |
| EPS Basic | 531.57% | 539.66% | 2,967.59% | 3,586.13% | -118.42% |
| Normalized Basic EPS | 12.11% | 13.24% | 5.66% | 7.18% | 24.31% |
| EPS Diluted | 516.32% | 508.16% | 3,749.92% | 4,218.39% | -118.91% |
| Normalized Diluted EPS | 11.74% | 12.81% | 4.87% | 6.46% | 24.08% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.37% | 0.39% | 0.33% |
| Average Diluted Shares Outstanding | 0.65% | 0.72% | 1.09% | 1.02% | 0.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |